Device manufacturer, as written on reports
Depuy Intl 8010379: medical device reports filed with FDA
1,972 reports name it as the manufacturer of the device involved, 2011–2017.
- 1,972
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 0.2%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
1,972 medical device reports received by FDA give Depuy Intl 8010379 as the manufacturer of the device involved, 0% of the MAUDE database, from August 2011 to October 2017. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.4%), death (0.3%) and malfunction (0.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Adapter Sleeves 12/14 +2 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 97 | 5 | 0.4% |
| Articuleze M Head 36mm +1 5 | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 94 | 24 | 0.1% |
| Pinnacle Mtl Ins Neut36idx52od | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 92 | 13 | 0.1% |
| Articuleze M Head 36mm +5 | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 79 | 24 | 0.1% |
| Pinnacle Mtl Ins Neut36idx50od | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 57 | 9 | 0% |
| Pinnacle Mtl Ins Neut36idx54od | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 54 | 11 | 0.1% |
| Articuleze M Head 36mm -2 | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 53 | 10 | 0.2% |
| Adapter Sleeves 12/14 +5 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 49 | 0 | 0.5% |
| Unknown Depuy Asr Acetabular Cup | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 49 | 0 | 0.2% |
| Unknown Depuy Femoral Head | Prosthesis, hip, hemi-, femoral, metal/polymer, cemented or uncemented | 46 | 0 | 0.1% |
| Unknown Depuy Pinnacle Metal Liner | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 41 | 0 | 0.3% |
| Unknown Depuy Xl Taper Sleeve Adaptor | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 40 | 0 | 0% |
| Asr Acetabular Cups 52 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 32 | 2 | 0.1% |
| Asr Uni Femoral Impl Size 46 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 31 | 2 | 0.1% |
| Articuleze M Head 36mm +8 5 | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 30 | 11 | 0.1% |
| Asr Tap Slv Adap 12/14 -1 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 28 | 0 | 0% |
| Pinnacle Mtl Ins Neut36idx56od | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 28 | 5 | 0.2% |
| Asr Acetabular Cups 50 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 23 | 0 | 0.1% |
| Asr Acetabular Cups 54 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 23 | 0 | 0.4% |
| Asr Uni Femoral Impl Size 47 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 23 | 0 | 0.4% |
| Asr Uni Femoral Impl Size 45 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 21 | 0 | 0.1% |
| Asr Acetabular Cups 56 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 20 | 0 | 0.4% |
| Adapter Sleeves 12/14 +8 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 18 | 0 | 0.3% |
| Asr Acetabular Cups 58 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 17 | 1 | 0.5% |
| Asr Uni Femoral Impl Size 49 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 16 | 0 | 0.4% |
| Pinnacle Mtl Ins Neut36idx58od | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 16 | 1 | 0.2% |
| Adapter Sleeve 11/13 +0 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 14 | 0 | 0.5% |
| Asr Acetabular Cups 60 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 14 | 0 | 0.3% |
| Taper Sleeve Adapter 12/14 +2 | Prosthesis, hip, semi-constrained (metal uncemented acetabular component) | 13 | 0 | 1.4% |
| Unknown Depuy Asr Head | Prosthesis, hip, femoral, resurfacing | 12 | 0 | 0.4% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Depuy Intl 8010379 reports
How many FDA device reports name Depuy Intl 8010379 as manufacturer?
1,972 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Adapter Sleeves 12/14 +2 (97), Articuleze M Head 36mm +1 5 (94), Pinnacle Mtl Ins Neut36idx52od (92), Articuleze M Head 36mm +5 (79) and Pinnacle Mtl Ins Neut36idx50od (57).
Which device types does it report on?
prosthesis, hip, semi-constrained (metal uncemented acetabular component) (61.2%), prosthesis, hip, semi-constrained, metal/polymer, cemented (22.6%), prosthesis, hip, femoral, resurfacing (4.6%) and prosthesis, hip, hemi-, femoral, metal/polymer, cemented or uncemented (4.5%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.